Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy

Paul T. Sobol, Jeanette E. Boudreau, Kyle Stephenson, Yonghong Wan, Brian D. Lichty, Karen L. Mossman

Research output: Contribution to journalArticlepeer-review

86 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds